Simon H. Stertzer

All filings by Simon H. Stertzer on record concern BioCardia, Inc. Between 16 December 2022 and 23 June 2026, the trades on record add up to 9 filings.

Every open-market trade on record is a purchase: 7 purchases worth €779k, and no sale. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. In 2026 alone, the filings show 2 purchases and no sales.

Half of the purchases are above €127k and half below. Clusters matter here: 5 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 5 purchases show a median change of -14.6%, with the price up in 0% of them. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 24 June 2026, reports an open-market purchase in BioCardia, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.